• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.12% Nasdaq Down 0.10%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.82 Up 0.06(2.17%) 9:40AM EDT - Nasdaq Real Time Price
    Prev Close:2.76
    Open:N/A
    Bid:2.65 x 100
    Ask:2.85 x 200
    1y Target Est:5.00
    Beta:1.60539
    Next Earnings Date:N/A
    Day's Range:2.76 - 2.82
    52wk Range:1.50 - 5.44
    Volume:11,850
    Avg Vol (3m):2,251,590
    Market Cap:270.34M
    P/E (ttm):N/A
    EPS (ttm):-0.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUUp 2.17%270.34M
    GSKUp 0.02%106.72B
    BIIBUp 0.66%68.23B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):81.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-17) :-0.47
    Quarterly EPS Est (Sep-16) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback